The stock was up 4% to Rs 561 on BSE in early morning trade, extending its past five days 14% rally, after the company announced the resolution of regulatory compliance issues at Halol plant. Sun Pharmaceutical Industries was up 4% to Rs 561 on BSE in early morning trade, extending its past five days 14% rally, after the company announced the resolution of regulatory compliance issues at Halol plant. In a stock exchange notification on Tuesday after market hours, Sun Pharma said it has received the Establishment Inspection Report (EIR) from the USFDA for the inspection conducted at its Halol plant during February 12-23.
To Get Free Trial
Missed call @ 9582541010
Call Us @ 8822117117
Mail Us = starindiamarket@gmail.com
Visit = http://www.starindiaresearch.com/freetrail.php
To Get Free Trial
Missed call @ 9582541010
Call Us @ 8822117117
Mail Us = starindiamarket@gmail.com
Visit = http://www.starindiaresearch.com/freetrail.php
This Information is really good and informative. Thanks for it.
ReplyDeleteCheck below links and get useful information.
Eris Lifesciences, Deepak Nitrite
Godrej Consumer Products